Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

New agents for diabetic nephropathy disclosed in recent Kowa patent

Oct. 7, 2008

Bone formation enhanced with GSK's calcium-sensing receptor antagonist ronacaleret

Oct. 7, 2008

BMD increased by percutaneous injection of novel GEM-OS2 in preclinical studies

Oct. 7, 2008

Novel treatments for endocrine-associated disorders imparted in recent patents

Oct. 6, 2008

New treatment option for Wilson's disease disclosed in recent SSV patent

Oct. 6, 2008

Addition of saxagliptin to a sulfonylurea or thiazolidinedione improves glucose control

Oct. 6, 2008

Merck & Co. discontinues taranabant development for obesity

Oct. 3, 2008

Ambrilia reports positive results for second phase III octreotide C2L study

Oct. 3, 2008

Plethora completes European phase III trial of PSD-502 for premature ejaculation

Oct. 3, 2008

Beta-cell function improved with R-1583, a novel long-acting GLP-1 analogue

Oct. 3, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 19, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Authorities work to quickly sequence Ebola species in latest outbreak
BioWorld
If the recent hantavirus outbreak wasn’t enough to keep public health officials busy, a new Ebola virus disease outbreak has been confirmed by authorities in the...
Camp4 studies CMP-002 in SYNGAP1 haploinsufficient mouse model
BioWorld Science
Camp4 Therapeutics Corp. has highlighted new preclinical data for CMP-002, the company’s lead investigational antisense oligonucleotide (ASO) therapeutic...